COMPANY OVERVIEW
PLATFORM TECHNOLOGY
PIPELINE
PATENT
NEWS & NOTICE
KR
ENG
NEWS & NOTICE
HOME
NEWS & NOTICE
NEWS
NEWS
NOTICE
NEWS
No.
Subject
Date
8
VC Investment trends in Bio sector
23.11.14
23.11.14
7
MolGenBio additional Pre A funding
23.11.14
23.11.14
6
Anticancer drug candidate MG-LZ (lenzidamide) : published in the Journal of the American Chemical Society regarding the highly efficient discovery method and excellent anticancer activity
23.08.31
23.08.31
5
Selected as Corporate for Innovation Field Startup Package by Ministry of SMEs and Startups(April 14, 2023)
23.07.19
23.07.19
4
Standigm – MolGenBio, business agreement to develop new drugs based on AI and synthetic biology.
23.01.26
23.01.26
3
Development of Genomic and Spectroscopic Signature-Based Platform Technology for the Discovery of Natural Macrolactams: published in Journal of the American Chemical Society
23.01.19
23.01.19
2
MolGenBio "Microbial genome scanning, legoization of biosynthetic genes, CNS targeting [the bell]
22.09.22
22.09.22
1
‘Drug development based on Synthetic biology’ MolGenBio, seed funding [the bell]
22.09.22
22.09.22